RxDoctor Payments Data

Roger Packer

Neurology · Washington, DCNPI 1821175167

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $30,467 of the $30,511 with a category attached, or 99.9%. 12 manufacturers reported payments, led by AstraZeneca at 28.6% of the total.

$30,511in general payments, 2019–2025

Across 17 payments — averaging $1794.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$9K
  • Day One Biopharmaceuticals$4K
  • Boehringer Ingelheim$4K
  • Y-mabs Therapeutics, Inc.$3K
  • Astrazeneca UK Limited$3K
  • Novartis$3K
  • plus $4K from 6 others
$291,093in research payments, 2019–2025

Across 9 payments — averaging $32,344 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$285K
  • Novartis Pharma AG$6K
  • Regeneron$415

What the payments were for

  • Consulting fees$30,467100%
  • Food & beverage$430%
  • Education$10%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,511 in reported general payments places this provider in the 80th percentile of 113 neurology providers in District of Columbia.

See all neurology providers in District of Columbia

Other neurology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →